Data for: Evaluating the Utility of Fasting Lipid Panel In Addition to Random Lipid Panel In Determining Lipid-Lowering Therapy in Acute Ischemic Stroke or TIA Patients

Published: 06-07-2020| Version 1 | DOI: 10.17632/y69wnv829s.1
Contributors:
Usman Shehzad,
Jason Mathew,
Archana Purushotham

Description

Objective. To determine if obtaining fasting lipid levels in addition to random lipid levels prompts changes in hyperlipidemia management of acute stroke patients. Methods. 206 patients met the study criteria which included a diagnosis of acute ischemic stroke or transient ischemic attack on admission and availability of both random and fasting LDL levels collected within 72 hours of each other. The dataset was analyzed to conform to the 2018 AHA/ACC guidelines using an LDL cutoff of 70 mg/dL. Results. In 206 patients, statin management would change based on the fasting LDL level in 12 patients, 11 of whom were in Group B. Our data suggests that lipid management is more likely to change if the initial random LDL falls between 70-99 mg/dL as compared to a value outside of this range (P<0.001).

Files